封堵器
蛋白酵素
蛋白酶
蛋白酶体
生物
细胞结
微生物学
紧密连接
细胞生物学
肝硬化
细胞
自发性细菌性腹膜炎
生物化学
内科学
医学
酶
作者
M Haderer,Philip Neubert,Eva Rinner,Annika Scholtis,Lucile Broncy,H Gschwendtner,Arne Kandulski,Vlad Pavel,Alexander Mehrl,Christoph Brochhausen,S Schlosser,Karsten Gülow,C Kunst,Martina Müller
出处
期刊:Gut
[BMJ]
日期:2021-03-11
卷期号:71 (3): 580-592
被引量:55
标识
DOI:10.1136/gutjnl-2020-321663
摘要
Objective Spontaneous bacterial peritonitis (SBP) is a life-threatening complication of liver cirrhosis with a 1-year mortality of 66%. Bacterial translocation (BT) from the intestine to the mesenteric lymph nodes is crucial for the pathogenesis of SBP. Design Since BT presupposes a leaky intestinal epithelium, the integrity of mucus and epithelial cell junctions (E-cadherin and occludin) was examined in colonic biopsies from patients with liver cirrhosis and controls. SBP-inducing Escherichia coli ( E. coli ) and Proteus mirabilis ( P. mirabilis ) were isolated from ascites of patients with liver cirrhosis and co-cultured with Caco-2 cells to characterise bacteria-to-cell effects. Results SBP-derived E. coli and P. mirabilis led to a marked reduction of cell-to-cell junctions in a dose-dependent and time-dependent manner. This effect was enhanced by a direct interaction of live bacteria with epithelial cells. Degradation of occludin is mediated via increased ubiquitination by the proteasome. Remarkably, a novel bacterial protease activity is of pivotal importance for the cleavage of E-cadherin. Conclusion Patients with liver cirrhosis show a reduced thickness of colonic mucus, which allows bacteria-to-epithelial cell contact. Intestinal bacteria induce degradation of occludin by exploiting the proteasome of epithelial cells. We identified a novel bacterial protease activity of patient-derived SBP-inducing bacteria, which is responsible for the cleavage of E-cadherin structures. Inhibition of this protease activity leads to stabilisation of cell junctions. Thus, targeting these mechanisms by blocking the ubiquitin-proteasome system and/or the bacterial protease activity might interfere with BT and constitute a novel innovative therapeutic strategy to prevent SBP in patients with liver cirrhosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI